Lee I, Byun BH, Kim BI, Choi CW, et al. Evaluating 64Cu-DOTA-rituximab as a PET agent in patients with B-cell lymphoma: a head-to-head comparison with 18F-fluorodeoxyglucose PET/computed tomography. Nucl Med Commun 2024 Aug 19. doi: 10.1097/MNM.0000000000001889.
PMID: 39155810